Results 81 to 90 of about 25,453,690 (257)

Neurofibromatosis Type 2 Presenting with Oculomotor Ophthalmoplegia and Distal Myopathy

Case Reports in Ophthalmological Medicine, 2016
Neurofibromatosis type 2 usually presents with bilateral acoustic schwannomas. We highlight the rare presentation of neurofibromatosis initially involving third nerve.
Jessica Mani Penny Tevaraj, Evelyn Tai Li Min, Raja Azmi Mohd Noor, Azhany Yaakub, Wan Hazabbah Wan Hitam   +4 more
doaj   +1 more source

Mouse Models of Neurofibromatosis 1 and 2

Neoplasia: An International Journal for Oncology Research, 2002
The neurofibromatoses represent two of the most common inherited tumor predisposition syndromes affecting the nervous system. Individuals with neurofibromatosis 1 (NF1) are prone to the development of astrocytomas and peripheral nerve sheath tumors ...
David H. Gutmann, Marco Giovannini
doaj   +1 more source

Neurofibromatosis 2: Primary Modality of Hearing Rehabilitation with Cochlear Implant. [PDF]

Indian J Otolaryngol Head Neck Surg, 2021
Halyur DA, Rayanagoudar PH, Kumar A, Dutt SN.   +3 more
europepmc   +1 more source

NEUROFIBROMATOSIS TIPO I

Medicentro, 2011
La neurofibromatosis (NF) es un trastorno hereditario caracterizado por la formación de neurofibromas (tumores que involucran al tejido nervioso) en la piel, tejido subcutáneo, nervios craneales y los nervios de la base de la columna vertebral1,2 ...
Teresa de los A. Casanova Rodríguez, Cecilio González Benavides, Sergio A. Rodríguez Jiménez   +2 more
doaj  

Pneumosinus dilatans and orbital meningioma in neurofibromatosis type 2

B-ENT, 2005
Pneumosinus dilatans and orbital meningioma in neurofibromatosis type 2. We report on a 9-year-old boy with neurofibromatosis type 2 and a progressive proptosis of the left eye.
T. Vauterin, I. Mombaerts, M. Jorissen, R. Sciot, E. Legius   +4 more
doaj   +2 more sources

Diagnostic and therapeutic process of neurofibromatosis type 1 and type 2

Journal of Education, Health and Sport
Neurofibromatosis is one of the most common genetic diseases. It is inherited in an autosomal dominant manner. It is divided into two genetically distinct subtypes, characterised by multiple skin lesions and tumours of the peripheral and central nervous 
Michał Leśniewski, Iwona Welian-Polus, Izabela Oleksak, Karolina Maliszewska   +3 more
doaj   +1 more source

The German version of the neurofibromatosis 2 impact on quality of life questionnaire correlates with severity of depression and physician-reported disease severity. [PDF]

Orphanet J Rare Dis, 2023
Lawson McLean AC, Freier A, Lawson McLean A, Kruse J, Rosahl S.   +4 more
europepmc   +1 more source

Building a precision therapeutics program at a tertiary care children's hospital

Pediatric Investigation, EarlyView.
Luke Hamilton, Heidi Trinkman, Diana Carrasco, Kaitlin Smith, Kelly Vallance, Alejandra Dominguez, Danielle Miller, Megan Gibbs, Anish Ray   +8 more
wiley   +1 more source

The Efficacy of Pharmacotherapy Intervention on Anthropometric Outcomes in Survivors of Childhood Brain Tumors: An Updated Systematic Review and Meta‐Analysis

Obesity Reviews, EarlyView.
ABSTRACT Introduction Many survivors of childhood brain tumors face long‐term adverse health outcomes like obesity. Uncertainties surround the effect of interventions to manage obesity‐related outcomes in survivors of childhood brain tumors. The goal of this updated systematic review and meta‐analysis was to provide the best estimate of the treatment ...
David Hart, Lawrence Mbuagbaw, Joseph Beyene, Marwa Akola, Sarah Burrow, M. Constantine Samaan, Lehana Thabane, Adam Fleming, Donna L. Johnston, Shahrad R. Rassekh, Laura Banfield, Russell J. de Souza   +11 more
wiley   +1 more source

Prospective phase II trial of the dual mTORC1/2 inhibitor vistusertib for progressive or symptomatic meningiomas in persons with neurofibromatosis 2. [PDF]

Neurooncol Adv, 2023
Jordan JT, Orr CC, Thalheimer RD, Cambillo JV, Beauchamp RL, Shaikh G, Muzikansky A, Stemmer-Rachamimov A, Giovannini M, Kalamarides M, Barker FG, Ramesh V, Plotkin SR.   +12 more
europepmc   +1 more source